secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARYA Sciences Acquisition Corp IV (—)
CIK:        0001838821
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001140361-24-010146
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ARYA Sciences SPAC gets Nasdaq delisting notice for failing to complete business combination within 36 months
--------------------------------------------------------------------------------

- Received Nasdaq staff notice on Feb 26, 2024 for non-compliance with IM-5101-2 (36-month deadline).
- Trading would be suspended March 6, 2024 unless hearing timely requested by March 4, 2024.
- ARYA has requested a hearing before Nasdaq Hearings Panel to stay suspension and complete business combination with Adagio Medical, Inc.
- No assurance ARYA will regain compliance or maintain Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1838821/000114036124010146/0001140361-24-010146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1838821/000114036124010146/ny20020899x12_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-010146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer